Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies.
Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.
Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.
A high-density SNP genetic linkage map for the silver-lipped pearl oyster, Pinctada maxima: a valuable resource for gene localisation and marker-assisted selection.
Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy.
See All 11 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy.
Patel SA. Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy. JAMA Oncol. 2019 03 01; 5(3):303-304.
View in:
PubMed
subject areas
Humans
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Neoplasms, Second Primary
authors with profiles
Shyam Ajay Patel MD, PhD